Key Highlights
- SPIMACO was the first pharmaceutical company listed on the Saudi Stock Exchange, showcasing its early commitment to transparency and investor relations.
- The company's production of the first biosimilar product entirely in Saudi Arabia highlights its leadership in biotechnology and pharmaceutical manufacturing.
- SPIMACO's strategic investments and subsidiaries demonstrate a diversified approach to growth and market expansion.
- The company's focus on innovation and excellence has consistently driven its success and industry leadership.
- SPIMACO's strong presence in the MENA region underscores its regional influence and commitment to serving the healthcare needs of the area.
About SPIMACO
SPIMACO is the leading pharmaceutical company in the MENA region, founded in 1986. It has a proud history of excellence and innovation, being the first pharmaceutical company listed on the Saudi Stock Exchange and producing the first biosimilar product entirely in Saudi Arabia. SPIMACO continues to pave the way for advancements in the industry, taking immense pride in its group, subsidiaries, and strategic investments. The company is headquartered in Riyadh, Saudi Arabia, and employs 2,502 people.
SPIMACO's commitment to innovation is evident in its pioneering efforts in the pharmaceutical sector. The company's strategic investments and subsidiaries further enhance its capabilities and market presence. SPIMACO's dedication to excellence and its significant contributions to the industry make it a key player in the MENA region.
The company's focus on innovation and excellence has positioned it as a leader in the pharmaceutical industry, with a strong presence in the MENA region. SPIMACO's achievements and strategic initiatives continue to drive its success and influence in the industry.
Company Facts
| Ownership Public Company |
Why Contact SPIMACO?
B2B professionals should contact SPIMACO for partnerships in pharmaceutical innovation, vendor opportunities in biosimilar production, and potential collaborations in biotechnology. SPIMACO's leadership in the MENA region offers a unique market access and growth potential.
Who Should Contact SPIMACO for Business?
Sales teams selling pharmaceutical products, recruiters seeking roles in biotechnology and pharmaceutical manufacturing, and partners offering services in biosimilar production should reach out to SPIMACO.
Categories
- Pharmaceutical
- Biosimilar
- Saudi Stock Exchange
- Innovation
- MENA region
- Biotechnology
- Pharmaceutical manufacturing
- Healthcare services
- Strategic investments
- Subsidiaries
More Pharmaceutical Manufacturing Companies
Frequently Asked Questions
- What does SPIMACO do?
- SPIMACO is a vertically integrated pharmaceutical manufacturer that produces tablets, capsules, syrup, creams, and injectables, including biosimilar products.
- How many employees does SPIMACO have?
- SPIMACO has approximately 2.5K employees.
- Where is SPIMACO headquartered?
- The company is headquartered in Riyadh, Saudi Arabia.
- What industry is SPIMACO in?
- SPIMACO operates in Pharmaceutical Manufacturing, Biotechnology, Healthcare Services.
- When was SPIMACO founded?
- SPIMACO was founded in 1986.
- Is SPIMACO still active?
- Yes, SPIMACO was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to SPIMACO?
- Research SPIMACO's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to SPIMACO?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with SPIMACO